International Surgery Journal
Pandya B et al. Int Surg J. 2015 Feb;2(1):105-108
http://www.ijsurgery.com
pISSN 2349-3305 | eISSN 2349-2902
DOI: 10.5455/2349-2902.isj20150223
Case Report
Occult insulinoma in a Meckel’s diverticulum: a case report
Bharati Pandya*, Ravinder Narang, Ulhas N. Jajoo
Department of Surgery, MGIMS, Sevagram, Wardha-442102, M.S., India
Received: 14 December 2014
Accepted: 30 December 2014
*Correspondence:
Dr. Bharati Pandya,
E-mail: Bharati_pandya@rediffmail.com
Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial
use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT
Insulinoma is a deceptive endocrine tumour of the pancreas due to its bizarre and nonspecific symptom complex. It is
also difficult to localize preoperatively, especially when present in an ectopic location. A 65 year old woman
presented with recurrent episodes of hypoglycaemia. She was erroneously under treatment for psychotic disorder. A
suspicion of insulinoma led us to investigate her further. Investigations revealed fasting hypoglycaemia, endogenous
hyperinsulinism, and a pancreatic parenchymal lesion. On exploration, an incidental Meckel’s diverticulum with a
nodule was also found. Histopathology showed an insulinoma of the Meckel’s diverticulum and a benign nonfunctioning adenoma in the pancreatic nodule. Surgery eventually resulted in restoration of euglycaemia and complete
disappearance of patient's symptoms.
Keywords: Occult insulinoma, Heterotopic pancreas, Neuroglycopenia, Meckel’s diverticulum
INTRODUCTION
Heterotopic or ectopic pancreas is pancreatic tissue
outside boundaries of pancreas without anatomic or
vascular connections to pancreas. It has a reported
frequency of 0 to 13.7%.1 It is usually found in the
stomach, duodenum and upper part of jejunum and less
commonly in the ileum, biliary system and spleen. Its
presence in Meckel’s diverticulum is well documented,
but rare. Neoplasms arising in Meckel’s diverticulae are
uncommon and those reported in the literature are mainly
carcinoid tumours, gastrointestinal stromal tumours, and
gastric,
intestinal
or
rarer
still
pancreatic
adenocarcinomas. To the best of our knowledge,
pancreatic insulinoma in a Meckel’s diverticulum has not
been reported before. An insulinoma is a neuroendocrine
tumor, deriving mainly from pancreatic islet cells. It is
usually solitary, sporadic and less than 2 cm in
dimension.2 It secretes insulin. Only 2-3% are
extrapancreatic in origin.2 Insulinomas are difficult to
diagnose and patients often get misdiagnosed with
psychiatric illnesses or seizure disorders. Localizing these
tumours is equally difficult. Occult insulinomas are
biochemically proven tumours with indiscriminate
anatomical site before operation. We describe a patient
who was found to have such a tumour. The clinical and
pathological aspect along with the related literature is
reviewed.
CASE REPORT
A 65-year-old woman presented with a 15 day history of
decreased oral intake and associated weakness. She was
on drugs for psychotic depression for the past 12 years
and had documented episodes of hypoglycaemia on her
previous admissions. Physical examination including a
thorough nervous system examination was unremarkable.
Investigations showed normal hemogram, kidney and
liver functions. During her hospital stay, she had frequent
episodes of early morning hypoglycaemia with associated
hunger binges, mental disturbances and violent
International Surgery Journal | January-March 2015 | Vol 2 | Issue 1
Page 105
Pandya B et al. Int Surg J. 2015 Feb;2(1):105-108
behaviour. Her blood sugar levels would drop to as low
as 37 mg/dl. Insulinoma was suspected and her Insulin
and C-peptide levels confirmed it. Abdominal ultrasound
did not show any pancreatic lesion. CECT imaging
revealed a 2 cm. lesion in the head of pancreas, with a
distinct tumour blush, but no evidence of metastasis or
lesions elsewhere.
Patient was accordingly prepared for laparotomy.
Pancreatic adenoma was palpable and was successfully
enucleated. On random inspection of the bowel, an
incidental Meckel’s diverticulum was found. CT scan
done preoperatively had failed to pick this up. It was 2
cm. in size with a narrow neck and 55cm. from the ileocaecal valve and had a 1.5 cm. nodule at the tip (Fig 2).
No other nodules, lymph nodes or evidence of
malignancy could be found on thorough exploration. In
view of a long-standing history, small size of the tumour,
absence of lymph nodes and narrow neck of the Meckel’s
diverticulum, wedge resection with adequate margin was
performed. Both the specimens were sent for
histopathology. Histopathology reported enucleated
pancreatic lesion to have multiple, mucinous, cystic
lesions with no evidence of neuroendocrine tumour. The
typical insulinoma was seen arising denovo from ectopic
pancreatic tissue present in the Meckel’s diverticulum.
There was no evidence of malignancy and resection
margins were clear. Postoperatively insulin drip was
required for a week. Her glucose levels stabilized
subsequently and full oral diet was resumed. She was
later discharged, euglycaemic and off anti-psychotic
therapy. On follow-up the patient is doing well for over
two years now.
Figure 1: Pancreatic adenoma being enucleated.
Figure 2: Meckel’s diverticulum with the insulinoma.
Figure 3: Histology: insulinoma (inset) in Meckel’s
diverticulum.
DISCUSSION
Hormone secreting pancreatic tumours with clinical
repercussions are rarely seen. Their occurrence has been
estimated to be 1-4 per million, per year.2 Insulinomas are
hormone secreting pancreatic tumours which present
clinically with symptoms of episodic hypoglycaemia.
They are usually solitary and less than 2 cm in size.2 Only
5-11% of these tumours are malignant.2 They have a
slight female preponderance (1.4:1 - female:male ratio)
and median age at diagnosis is about 47 years.2 These
tumours pose a diagnostic challenge owing to their
dramatic, at times, puzzling presentations. Diagnosis may
be delayed because symptoms are nonspecific.
Neuroglycopenic symptoms are chiefly seen in these
patients and they are misdiagnosed as epilepsy or
neuropsychiatric disorder in as high as 20% cases.3,6 Our
patient was 65 years old and was shuffling between
physicians and psychiatrists for the past 12 years. A
strong index of suspicion and relevant investigations led
us to the diagnosis. In patients with insulinoma, other
than behavioral changes, diplopia, sweating and
palpitations are seen at a rate of 85%; confusion or
abnormal behavior in 80%, unconsciousness and amnesia
is seen in 53% and epilepsy in 12%.6
Insulinomas were the first pancreatic neuroendocrine
tumors to be identified, as reported by Whipple &
Frantz.8 97-98% Insulinomas are intrapancreatic and only
2-3% of these tumours are in ectopic locations.2 The first
resection of an insulinoma was performed in 1927, when
W. J. Mayo removed an insulin-secreting tumor and
injected its extracts into rabbits, they subsequently
developed hypoglycemia. A classic history of
hyperinsulinaemic, hypoglycaemic syndrome, which
responds to administration of glucose in a clinical setting,
suggests the diagnosis of an insulinoma (Whipple’s
triad). Insulinoma is diagnosed biochemically with low
blood glucose; elevated insulin, C-peptide and proinsulin
levels.
Meckel’s diverticulum is the most prevalent (2%)
congenital abnormality of the gut, but is often difficult to
diagnose.9 Overall tumors that arise in Meckel’s
International Surgery Journal | January-March 2015 | Vol 2 | Issue 1
Page 106
Pandya B et al. Int Surg J. 2015 Feb;2(1):105-108
diverticulum are rare and occur in only 0.5% to 1.9% of
cases.4 Majority of them are carcinoids (33%), followed
by gastrointestinal stromal tumours, benign leiomyomas
and less commonly gastric, intestinal and benign or
malignant pancreatic exocrine tumours (3.2%).5 Ectopic
tissue, found in 50 percent of them, consists of gastric
tissue in 60 to 85 percent and pancreatic tissue in 5 to 16
percent cases.9 Gastric mucosa is more often found at the
base while the pancreatic tissue is more at the apex or tip
of the Meckel’s diverticulum.9 Meckel’s diverticulum is
typically short and wide mouthed, which makes its
detection difficult.9 The success rates of investigations as
reported by Groebli et al are, small bowel enema 36%,
99mTc scan 75%, angiography 33%, and computed
tomography only 7%.11 Overall tumors that arise in
Meckel’s diverticulum are rare and occur in only 0.5% to
1.9% of cases.4 The majority of them are carcinoids
(33%), followed by gastrointestinal stromal tumours,
benign leiomyomas and less commonly gastric, intestinal
and benign or malignant pancreatic exocrine tumours
(3.2%).5 In our patient even on retrospect, Meckel’s
diverticulum could not be detected on CT scan and the
Meckel’s diverticulum had a narrow neck with a 1.5 cm
nodule confined to the tip of the diverticulum. There were
no evident lymphnodes or metastatic lesions and wedge
resection was giving adequate margins. Lopez et al.12
observed that malignant tumours are characterized by a
shorter history, age over 50 years, weight loss (as
opposed to weight gain seen in benign), more severe
hypoglycaemia, tumour size more than 2 cm, its
multiplicity and presence of lymphnodes or liver
secondaries. These characteristics aid in clinical
assessment of insulinomas.
Localization of insulinomas is difficult owing to its small
dimension and occasional ectopic location.2,12 Inability to
preoperatively localize a biochemically proven tumour
led clinicians to coin the term ‘occult insulinoma’.
Localization usually is done by computed tomography,
MRI, or transabdominal and endoscopic ultrasonography.
Best localization has been reported with somatostatin
receptor scintigraphy,2 which helps even when the
tumours are in ectopic locations. Machado et al. have
observed that, notwithstanding the progress of diagnostic
methods during the latest years, the identification of
insulinomas remains a difficult clinical problem both for
clinicians and surgeons. According to Norton et al.
intraoperative ultrasound (IOUS) for the treatment of
benign insulinomas is the best modality for precise
operative localization. The definitive treatment is surgical
removal of the tumor, which gives 90% success.6
Laparoscopic surgery for localized lesions is increasingly
being reported. Medical treatment is reserved only for
unresectable tumors, preoperative preparation or for
unsuitable candidates for surgery.
CONCLUSION
index of suspicion is required because the presentation of
neuroglycopenic symptoms can be elusive. An even
greater challenge is in localizing these rare pancreatic
endocrine tumours especially when in heterotopic
location. Here we have presented an occult insulinoma in
a very rare location, the Meckel’s diverticulum. In this
case a lesion diagnosed on CT, erroneously led us to
believe that it was a pancreatic adenoma we were dealing
with. Intraoperatively we detected another suspicious
lesion which later on was proved to be a benign occult
insulinoma arising denovo in a Meckel’s diverticulum.
This experience suggests that a meticulous laparotomy
despite all available diagnostic modalities, should not be
skipped.
Funding: No funding sources
Conflict of interest: None declared
Ethical approval: Not required
REFERENCES
1.
2.
3.
4.
5.
6.
7.
8.
9.
Allison JW, Johnson JF III, Barr LL, Warner BW,
Stevenson RJ. Induction of gastroduodenal prolapse
by antral heterotopic pancreas. Pediatr Radiol.
1995;25:50-1.
Bassam Abboud, Joe Boujaoude. Occult sporadic
insulinoma: Localization and surgical strategy. J
World Gastroenterol. 2008 Feb;14(5):657-65.
Service FJ, McMahom MM. Functioning
insülinoma-incidence, recurrence and long term
survival of patient: a 60 year study. Mayo Clin Proc.
1991;66(7):771-9.
Justin MM. Cates, Timothy L. Williams, Arief A.
Suriawinata. Intraductal papillary mucinous
adenoma that arises from pancreatic heterotopia
within a Meckel’s diverticulum. Arch Pathol Lab
Med. 2005 Mar;129(3):e67-9.
Hoey C. Koh, Blaithin Page, Catherine Black, Ian
Brown, Stuart Ballantyne, David J. Galloway.
Ectopic pancreatic-type malignancy presenting in a
Meckel’s diverticulum: a case report and review of
literature. World J Surg Oncol. 2009;7:54.
Mesut Ozkaya, Mehmet F. Yuzbasioglu, Irfan
Koruk, Erman Cakal, Mustafa Sahin, Basak Cakal.
Preoperative detection of insulinomas: two case
reports. Cases J. 2008;1:362.
Ana Cláudia Ferreira Rosa, Márcio Martins
Machado, Marcella Stival Lemes, Mariana Caetano
Barreto, Rodrigo Alvarenga Nunes, Nestor de
Barros, et al. Intraoperative ultrasonographic
evaluation of insulinomas: an update. Radiol Bras.
2006. Sep/Oct;39(5):361-5.
Whipple AO, Franz VK. Adenoma of islet cells with
hyperinsulinism. Am Surg. 1935;101:1299-335.
John P. Martin, Pamela D. Connor, Kerri Charles,
JD,
University
of
Tennessee.
Meckel’s
diverticulum.
Am
Fam
Physician.
2000
Feb;61(4):1037-42.
A clinical setting of Whipple’s triad is strongly
suggestive of an insulinoma. Nonetheless, a very high
International Surgery Journal | January-March 2015 | Vol 2 | Issue 1
Page 107
Pandya B et al. Int Surg J. 2015 Feb;2(1):105-108
10. John J. Park, Bruce G. Wolff, Matthew K.
Tollefson, Erin E. Walsh, Dirk R. Larson. Meckel’s
diverticulum. Ann Surg. 2005 Mar;241(3):529-33.
11. Groebli Y, Bertin D, Morel P. Meckel’s
diverticulum in adults: retrospective analysis of 119
cases and historical review. Eur J Surg. 2001
Jul;167(7):518-24.
12. López Alvarenga JC, Cáceres Agreda N, Rivera L,
Gamboa A, Gómez Pérez FJ, Rull JA. Diagnosis of
malignant and benign insulinoma. Experience of the
National Institute of Nutrition. Rev Invest Clin.
1999 May-Jun;51(3):167-73.
DOI: 10.5455/2349-2902.isj20150223
Cite this article as: Pandya B, Narang R, Jajoo UN.
Occult insulinoma in a Meckel’s diverticulum: a case
report. Int Surg J 2015;2:105-8.
International Surgery Journal | January-March 2015 | Vol 2 | Issue 1
View publication stats
Page 108